Negative HBcAg in immunohistochemistry assay of liver biopsy is a predictive factor for the treatment of patients with nucleos(t)ide analogue therapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1582-4934|22|3|1675-1683

ISSN: 1582-1838

Source: Journal of Cellular and Molecular Medicine, Vol.22, Iss.3, 2018-03, pp. : 1675-1683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract